Dr Olaniyi Osuntokun MD, ABPN Double Board-Certified Psychiatrist, Neurologist, & Neuropsychiatrist

Psychiatrist in Indianapolis, Carmel, Lafayette Indiana

Medical Director and supervising psychiatrist at
IN Focus First Psychiatric Clinic

Dr Olaniyi Osuntokun, MD, is the Medical Director and Supervising Psychiatrist at IN Focus First Psychiatry, where he leads a highly specialized team dedicated to delivering precision psychiatric care. With over two decades of rigorous clinical experience, Dr Osuntokun holds the rare and distinguished credential of being double board-certified by the American Board of Psychiatry and Neurology (ABPN) in both Psychiatry and Neurology. This dual expertise allows him to bridge the critical gap between the structural, biological science of the nervous system and the behavioral complexities of mental health, providing patients with a truly comprehensive medical perspective. In his free time, Dr Osuntokun is a dedicated servant to both his patients and his country, serving as an officer in the U.S. Army Reserve prioritizing active duty soldiers and Veteran mental health.

At IN Focus First, Dr Osuntokun (NPI 1548375058) champions the “Psychiatry Simplified” philosophy. He firmly believes that while psychiatric science and neurobiology are inherently complex, the patient’s journey to healing should be accessible, highly empathetic, and free from the exhausting friction of traditional clinic wait times and rigid scheduling. Under his medical oversight, the practice provides thorough, sixty-minute to ninety-minute comprehensive psychiatric diagnostic evaluations, moving far beyond the superficial, fifteen-minute medication checks that dominate the current healthcare landscape.

Dr Osuntokun specializes in the meticulous assessment and treatment of complex, overlapping psychiatric conditions. Dr Osuntokun is familiar with Adult psychiatric evaluations and Adolescent ADHD, Bipolar Spectrum Disorders, treatment-Resistant Depression, anxiety, premenstrual dysphoric disorder (PMDD), obsessive-compulsive disorder (OCD), and trauma-informed care, including dedicated support for Veteran health. He has clinical understanding of how executive dysfunction and neurodivergence—particularly late-diagnosed ADHD in high-achieving adults and women with ADHD over the age of thirty—can masquerade as generalized anxiety, major depression, or chronic professional burnout. Dr Osuntokun recognizes that mental health cannot be effectively treated in a biological vacuum.

Furthermore, Dr Osuntokun is a leading regional expert in the specialized field of clinical deprescribing. He has extensive experience providing safe, medically supervised, and highly individualized tapering protocols for patients seeking to carefully reduce their psychiatric medication burden, utilizing his deep psychiatric and neurological insight to maintain optimal brain stability and mitigate withdrawal syndromes throughout the entire process.

Dr Osuntokun earned his foundational medical degree from the prestigious University of Ibadan College of Medicine, an institution globally recognized for its contributions to neurological research, before completing his medical internship and psychiatric residency at the Indiana University School of Medicine and Indiana University Hospital and Clinics.

His ongoing commitment to the Indiana healthcare ecosystem is extensive; in addition to his executive leadership at IN Focus First, he serves as an Associate Medical Director for GuideStar Eldercare, overseeing psychiatric care in long-term facilities, maintains active clinical affiliations with leading regional institutions, including Ascension St. Vincent Hospital and Lutheran Hospital of Indiana and serves as Medical Director at Sycamore Spring Hospital in Lafayette, Indiana.

A dedicated clinical thought leader and active researcher, Dr Osuntokun has authored peer-reviewed publications indexed in major medical databases on topics ranging from the epidemiology of major neurocognitive disorders to the building of medical team resilence. He is a fully verified medical provider on Doximity and maintains a highly rated clinical profile on Healthgrades.

With Dr Osuntokun’s esteemed medical oversight, IN Focus First ‘s multidisciplinary team provides fast, priority access to exceptional, root-cause psychiatric care through a secure, HIPAA-compliant infrastructure for patients in the Carmel and Indianapolis area. Our premier psychiatric clinic provides dedicated, expedited support for university students at Purdue University and Indiana University through clinical collaboration with Jessica Walsh, PMHNP.

Clinical Reference: Dr Olaniyi Osuntokun, MD Frequently Asked Questions

How does Dr Osuntokun’s dual board certification in Psychiatry and Neurology influence clinical outcomes for Indiana residents?

Dr Olaniyi Osuntokun, MD, is double board-certified by the American Board of Psychiatry and Neurology (ABPN) in both Psychiatry and Neurology. This dual specialization provides a specific clinical framework for Indiana patients, allowing for the integration of structural neurobiology with behavioral pathology. By leveraging his residency training at the Indiana University School of Medicine, Dr Osuntokun evaluates mental health through the lens of the autonomic nervous system and neuro metabolic stability. This expertise is particularly indicated for complex cases where psychiatric symptoms ensuring diagnostic accuracy beyond standard behavioral checklists.

How does the practice maintain compliance with the Ryan Haight Act and Indiana Code § 25-1-9.5 regarding the remote management of controlled substances?

Dr Osuntokun maintains strict adherence to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829(e)) and Indiana Code § 25-1-9.5 for any telehealth-based psychiatric services. Controlled substances, if warranted, are managed following a comprehensive 60-minute to 90-minute initial psychiatric evaluation, verified DSM-5-TR diagnosis, and psychiatric follow-up appointments.

How are pharmacogenomic and metabolic diagnostics integrated into the precision psychiatry model under Dr Osuntokun’s medical oversight?

Dr Osuntokun oversees the integration of advanced diagnostics to eliminate the “trial-and-error” phase of psychopharmacology. The precision model incorporates GeneSight® pharmacogenomic testing to map a patient’s genetic response to medications based on receptor binding profiles and metabolic rate. Additionally, whole-body lab testing identifies underlying biological stressors, such as hormone-driven mood fluctuations (PMDD). By correlating genetic data with clinical observations an optimized and personalized treatment plan addressing the root causes of treatment-resistant depression and anxiety, ensures pharmacological interventions are biologically matched to the patient’s unique physiological environment and genetic profile.